ASKION
Private Company
Total funding raised: $17.5M
Overview
Founded in 1991 and based in Gera, Germany, ASKION has developed into a specialized provider of advanced, automated biobanking systems. Its core offering, the modular ASKION C-line®, enables scalable, GMP-compliant storage and handling of biological samples for the biologics and cell therapy sectors. The company addresses the critical need for reproducibility, sample integrity, and data traceability in managing sample collections ranging from a few thousand to millions of specimens. ASKION operates as a technology and services provider within the life sciences tools and infrastructure market.
Technology Platform
The ASKION C-line® is a modular, automated system for cryogenic biobanking. It integrates controlled freezing, robotic sample storage/retrieval in nitrogen gas phase (down to -185°C), cryogenic sample identification, and dedicated software for full sample lifecycle documentation and compliance.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
ASKION competes in the automated cryogenic storage segment against companies like Brooks Life Sciences (BioStore, SampleStore), Hamilton Storage, and Stirling Ultracold. It differentiates through deep cryogenic automation (handling at -130°C), modular scalability, and a strong focus on the complete workflow from freezing to documentation. Larger competitors may have broader product portfolios and sales reach.